Logo image of BIO.DE

BIOTEST AG (BIO.DE) Stock Analyst Earnings Estimates

FRA:BIO - Deutsche Boerse Ag - DE0005227201 - Common Stock - Currency: EUR

40.8  -1 (-2.39%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025
Revenue
YoY % growth
BIO.DE revenue by date.BIO.DE revenue by date.
515.6M
6.48%
516.1M
0.10%
684.6M
32.65%
642.36M
-6.17%
719.12M
11.95%
EBITDA
YoY % growth
BIO.DE ebitda by date.BIO.DE ebitda by date.
-19.1M
-169.96%
19.2M
200.52%
156.2M
713.54%
55.55M
-64.44%
149.48M
169.09%
EBIT
YoY % growth
BIO.DE ebit by date.BIO.DE ebit by date.
-50.2M
-2,082.61%
-16.6M
66.93%
120.3M
824.70%
16.16M
-86.57%
108.07M
568.75%
Operating Margin
BIO.DE operating margin by date.BIO.DE operating margin by date.
-9.74%-3.22%17.57%2.52%15.03%
EPS
YoY % growth
BIO.DE eps by date.BIO.DE eps by date.
N/A
-98.39%
N/A
47.88%
N/A-0.101.52
1,600.00%

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth

341.67%
0.29%
Q4 2021
Q2Q % growth

-1,112.00%
-0.12%
Q4 2020
Q2Q % growth
-0.01 -0.650.6498.45%
BIO.DE Yearly EPS VS EstimatesBIO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 -1
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
150.7M
-40.39%
%
Q2 2024
Q2Q % growth
156.8M
-36.65%
%
Q1 2024
Q2Q % growth
215.2M
83.62%
%
Q4 2023
Q2Q % growth
184.3M
18.67%
%
Q3 2023
Q2Q % growth
252.8M
134.73%
%
Q2 2023
Q2Q % growth
247.5M
80.39%
%
Q1 2023
Q2Q % growth
117.2M
1.12%
%
Q4 2022
Q2Q % growth
155.3M
7.70%
639.45M-484.15M-75.71%
Q3 2022
Q2Q % growth
107.7M
-5.19%
%
Q2 2022
Q2Q % growth
137.2M
-0.44%
%
Q1 2022
Q2Q % growth
115.9M
-3.42%
%
Q4 2021
Q2Q % growth
144.2M
1.12%
532.875M-388.675M-72.94%
Q3 2021
Q2Q % growth
113.6M
6.37%
%
Q2 2021
Q2Q % growth
137.8M
0.51%
%
Q1 2021
Q2Q % growth
120M
22.82%
%
Q4 2020
Q2Q % growth
142.6M
14.81%
463.855M-321.255M-69.26%
Q3 2020
Q2Q % growth
106.8M
7.01%
%
Q2 2020
Q2Q % growth
137.1M
16.58%
%
Q1 2020
Q2Q % growth
97.7M
26.06%
%
Q1 2019
Q2Q % growth
77.5M 78.78M-1.28M-1.62%
BIO.DE Yearly Revenue VS EstimatesBIO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 0%
RevenueN/A N/A 0% 0%